1. <1043> Ancillary materials for cell, gene, and tissue
engineered products. In: USP38-NF33. Rockville, MD: US Pharmacopeial Convention;
2016:896.
2. Guidance for FDA Reviewers and Sponsors: Content and Review of
Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell
Therapy Investigational New Drug Applications (INDs), April 2008. Available at the
Food and Drug Administration Web site. http://www.fda.gov, Accessed April 28, 2016
3. Sakamoto N, Tsuji K, Muul LM, Lawler AM, Petricoin EF, Candotti F,
et al. Bovine apolipoprotein B-100 is a
dominant immunogen in therapeutic cell populations cultured in fetal calf serum in
mice and humans. Blood. 2007;110(2):501–8.
4. Guidance for industry: nonclinical studies for the safety
evaluation of pharmaceutical excipients, May 2005. Available at the Food and Drug
Administration Web site. http://www.fda.gov, Accessed April 28, 2016
5. International Conference on Harmonisation of Technical Requirements
for Registration of Pharmaceuticals for Human Use (ICH) Q8 Pharmaceutical
Development (R2), August 2009. Available at the ICH website: http://www.ich.org, Accessed April 28, 2016